ESR1 and ovarian carcinoma: PDMS releases endocrine disruptors, which could be of concern over long times in culture and have been shown to transactivate the estrogen receptor in an ovarian carcinoma cell line stably transfected with an estrogen receptor element and a luciferase transporter gene [81].